Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates

Sponsor
RTI International (Other)
Overall Status
Terminated
CT.gov ID
NCT02214667
Collaborator
University of North Carolina, Chapel Hill (Other), Boston University (Other)
8
1
2
49.3
0.2

Study Details

Study Description

Brief Summary

Treatment adaptation and implementation study for adult jail inmates with co-occurring substance use disorders.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Dual-diagnosis motivational interviewing (DDMI)
  • Behavioral: Integrated group therapy (IGT)
  • Behavioral: Jail and community-based behavioral health services
N/A

Detailed Description

We will adapt dual-diagnosis motivational interviewing and integrated group therapy for jail inmates with co-occurring substance use and mental health disorders and to evaluate the feasibility of implementing the adapted interventions and associated research and communication protocols.

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates
Actual Study Start Date :
May 21, 2015
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: DDMI-IGT

Subjects randomized to the experimental condition will receive adapted versions of dual-diagnosis motivational interviewing ([DDMI] one session before release from jail) and integrated group therapy ([IGT] 12 community-based sessions over a 2-month period).

Behavioral: Dual-diagnosis motivational interviewing (DDMI)
DDMI is an evidence-based adaptation to motivational interviewing. DDMI incorporates an integrated framework and accommodates cognitive impairments and disordered thinking associated with co-occurring substance use and mental disorders.

Behavioral: Integrated group therapy (IGT)
IGT is an evidence-based practice for treating co-occurring disorders. IGT focuses on relapse prevention by reducing substance use and stabilizing psychiatric symptoms.

Active Comparator: Usual care

Subjects randomized to the usual care condition will receive jail and community-based behavioral health services.

Behavioral: Jail and community-based behavioral health services
Existing behavioral health service programs

Outcome Measures

Primary Outcome Measures

  1. Acceptability [Study months 21 through 34]

    Client Satisfaction Questionnaire-8, Narrative Evaluation of Intervention Interview

Secondary Outcome Measures

  1. Feasibility of Adapted Interventions [Study months 21 through 34]

    How successfully can the adapted interventions be implemented (Focus Group interviews)

  2. Fidelity [Study months 21 through 34]

    DDMI and IGT Adherence Forms

  3. Substance use [Study months 20 through 30]

    Addiction Severity Index

  4. Psychiatric symptoms [Study months 20 through 30]

    Brief Psychiatric Rating Scale

  5. Health status [Study months 20 through 30]

    SF-12

  6. Service use [Study months 20 through 30]

    Epidemiological Catchment Area Interview

  7. Externalizing behaviors [Study months 20 through 30]

    Triarchic Psychopathy Measure

  8. Quality of life measure [Study months 20 through 30]

    Heinrichs-Carpenter Quality of Life Scale, Plus

  9. Arrest [Study months 20 through 30]

    Self-report and official jail records

  10. Treatment preferences [Study months 20 through 30]

    Visual analog ranking of 8 different aspects of treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • (1) drug or alcohol abuse or dependence and SMI (major depressive disorder; depressive disorder not otherwise specified [NOS]; bipolar disorder I, II, or NOS; schizophrenia spectrum disorder; schizoaffective disorder; schizophreniform disorder; brief psychotic disorder; delusional disorder; or psychotic disorder NOS);

  • (2) resident of Wake County and detained in The Jail;

  • (3) >18 years of age; (4) able to speak/read English; and (5) able to provide informed consent.

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 RTI International Research Triangle Park North Carolina United States 27709

Sponsors and Collaborators

  • RTI International
  • University of North Carolina, Chapel Hill
  • Boston University

Investigators

  • Principal Investigator: Richard A Van Dorn, Ph.D., RTI International

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
RTI International
ClinicalTrials.gov Identifier:
NCT02214667
Other Study ID Numbers:
  • R34DA036791
First Posted:
Aug 12, 2014
Last Update Posted:
Mar 17, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by RTI International
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2020